FDA decision supported by an interim clinical study report on patient safety Grand Rapids, Mich., February 28, 2023— cultivate(MD) Capital Funds LP, funds that are
Grand Rapids, Mich., January 10th, 2023 — cultivate(MD) Capital Funds LP, funds that are focused on investments into early-stage healthcare companies with innovative technologies, announced today that
WARSAW, Ind., Jan. 5, 2023 /PRNewswire/ — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that it has
Grand Rapids, Mich., December 7, 2022 — HAPPE Spine announces that Andrew Iott has accepted an offer to become the President and CEO. Mr. Iott
Grand Rapids, Mich., October 5th, 2022— cultivate(MD) Capital Funds LP, funds that are focused on investments into early-stage healthcare companies with innovative technologies, announces today
Funds to Support Commercial Expansion and Post-Market Clinical Studies of Tapestry® for tendon and ligament injuries.
Grand Rapids, MI, July 25th, 2022 — Genesis Innovation Group’s cultivate(MD) Capital Funds LP, funds that are focused on investments into early-stage healthcare companies with
Grand Rapids, MI, June 06, 2022 — Genesis Innovation Group’s cultivate(MD) Capital Funds LP, funds that are focused on investments into early-stage healthcare companies with innovative technologies, announced today
FDA decision supported by an interim clinical study report on patient safety Lincoln, Neb. – April 19, 2022 – Virtual Incision Corporation, a medical device
